FCMR

Across TCGA pan-cancer cohorts, FCMR Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FCMR data layer compared with 23 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FCMR Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FCMR expression acts as an unfavorable survival marker.

HNSC, KIRP, and SARC are the cancer types where FCMR Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	II,III,IV	0.209	0.650	.019	12	view →
KIRP	OS	Median	All	0.105	0.688	.004	6	view →
SARC	OS	Median	All	0.241	0.766	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FCMR–HNSC (OS)

Open the HNSC breakdown →